Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors
Journal Title: Turkish Journal of Pathology - Year 2017, Vol 33, Issue 3
Abstract
Objective: Programmed death ligand 1 (PD-L1) found on tumor cells has recently been reported to have a key role in the development and dissemination of many tumors, such as lung and breast carcinomas. In this study, we retrospectively analyzed PD-L1 expression among different types of sarcomas. Material and Method: Tissue microarrays of 3-4 mm diameter were composed from paraffin blocks of 222 various sarcomas. Slides prepared from microarrays were stained for PD-L1 antibody (Cell Signaling, E1L3N®) using Leica Bond Autostainer. Any membranous staining over 5% of the cells was regarded as positive. Quantitative real-time PCR with TaqMan gene expression assays for PDL1 was performed using whole sections from FFPE tissue of PD-L1 positive cases, by normalizing absolute values to β-actin. Relative expression level of mRNA of PDL1 was calculated and scored using Log102(threshold cycle of b-actin - threshold cycle of PDL1). Results: Immunohistochemically, PD-L1 expression was present in 34 of 222 (15%) sarcomas. 5/13 (39%) undifferentiated pleomorphic sarcomas, 6/18 (33%) malignant peripheral nerve sheath tumors, 5/16 (31%) dedifferentiated liposarcomas, 4/19 (21%) rhabdomyosarcomas, 2/16 (13%) epithelioid sarcomas, 2/15 (13%) leiomyosarcomas, 3/26 (12%) synovial sarcomas, 1/18 (6%) myxoid liposarcoma, 1/2 (50%) extraskeletal myxoid chondrosarcoma, 1/3 (33%) alveolar soft part sarcoma, 1/3 (33%) parachordoma/myoepithelioma, 1/5 (20%) pleomorphic liposarcoma, 1/7 (14%) angiosarcoma, 1/8 (13%) Ewing sarcoma showed PD-L1 expression. Cases of solitary fibrous tumor/hemangiopericytoma (18), desmoplastic round cell tumor (14), Ewing-like sarcoma (6), epithelioid hemangioendothelioma (5), clear cell sarcoma (4), myxofibrosarcoma (4), low grade fibromyxoid sarcoma (2) were all negative. Tumor-infiltrating hematopoietic cells were positive for PD-L1 in 32 cases (15%) with only 2 cases overlapping with PD-L1 staining in tumoral cells. Sixteen of 34 (47%) immunohistochemically PD-L1 positive cases showed significant but low-level PD-L1 mRNA overexpression. Conclusion: We have shown PD-L1 expression in a subset of sarcomas, both at the protein and mRNA level. High-grade pleomorphic sarcomas tend to show more frequent PD-L1 expression. Clinical trials are necessary to further assess the effect of anti PD-L1 drugs on sarcomas showing PD-L1 expression.
Authors and Affiliations
Kemal KÖSEMEHMETOĞLU, Ece ÖZOĞUL, Berrin BABAOĞLU, Gaye GÜLER TEZEL, Gökhan GEDİKOĞLU
Keywords
Related Articles
- EP ID EP255187
- DOI 10.5146/tjpath.2017.01395
- Views 100
- Downloads 0
Enteropati-tipi T-hücreli lenfoma olgularında EBER in situ hibridizasyon yöntemiyle Epstein-Barr virüs ilişkisinin araştırılması
“Enteropati-tipi T-hücreli lenfoma (ETTHL)”, intraepitelyal T-lenfositleri kökenli bir “matür ekstranodal T ve NK hücreli lenfoma” türüdür. Tüm non-Hodgkin lenfomalar içerisindeki oranı %1'in altındadır. Gelişiminde glia...
Pediatric Intracranial Ependymal Tumors: Clinicopathologic Evaluation of 28 Cases
Objective: In the present study we aimed to assess the prognostic value of age, tumor localization, extent of surgery, histological grade, p53 protein and Ki67 proliferation index in pediatric cases diagnosed as ependymo...
Intra-Articular Glomus Tumor– A Rare Presentation
-
Böbrekte kitle nedeniyle yapılan iğne kor biyopsileri ve tanı zorlukları
Amaç: Kitle lezyonları için böbrek iğne kor biyopsileri, sıklıkla ileri dönem böbrek hücreli karsinom ve çok sayıda kitle lezyonunun (primer böbrek hücreli karsinom veya metastatik böbrek kitlesi) olduğu durumlarda uygul...
Needle core biopsies for renal masses and diagnostic difficulties
Aim: Renal needle core biopsies for mass lesions are being used frequently in advanced renal cell carcinoma or multipl mass lesions (e.g., primary renal cell carcinoma or metastatic renal mass). The problems and clues of...